Improved Efficacy Using Rituximab and Brief Duration, High Intensity Chemotherapy With Filgrastim Support for Burkitt or Aggressive Lymphomas: Cancer and Leukemia Group B Study 10 002
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.12736
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 15, 2014
Authors
Publisher
Wiley